Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
PrECOG, LLC.
PrECOG, LLC.
Fundación GECP
Bristol-Myers Squibb
Peking University Cancer Hospital & Institute
Aetion, Inc.
Aetion, Inc.
Ain Shams University
European Lung Cancer Working Party
Sungkyunkwan University
Daiichi Sankyo
Wake Forest University Health Sciences
Ziekenhuis Oost-Limburg
Roswell Park Cancer Institute